| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |